Mackay moves to AZ as Dolsten takes Pfizer’s R&D crown

Pfizer has announced a big change-up at the top of its R&D empire as it continues to meld its development program with Wyeth's. Mikael Dolsten (photo), M.D., PhD., the former head of Wyeth's R&D, has been named the global chief of Pfizer research and development as Martin Mackay (photo) bolts Pfizer to take the same job at AstraZeneca. The move to push Dolsten to the top ends Pfizer's short experiment with a two-track approach to development. Post-merger Pfizer had...